Lapatinib in advanced chordoma: A phase II study

被引:0
|
作者
Stacchiotti, Silvia
Tamborini, Elena
Palassini, Elena
Negri, Tiziana
Marrari, Andrea
Messina, Antonella
Morosi, Carlo
De Troia, Beatrice
Longhi, Alessandra
Palmerini, Emanuela
Gronchi, Alessandro
Pilotti, Silvana
Casali, Paolo Giovanni
机构
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Ist Ortoped Rizzoli, Bologna, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10026
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Phase II study on lapatinib in advanced EGFR-positive chordoma
    Stacchiotti, S.
    Tamborini, E.
    Lo Vullo, S.
    Bozzi, F.
    Messina, A.
    Morosi, C.
    Casale, A.
    Crippa, F.
    Conca, E.
    Negri, T.
    Palassini, E.
    Marrari, A.
    Palmerini, E.
    Mariani, L.
    Gronchi, A.
    Pilotti, S.
    Casali, P. G.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1931 - 1936
  • [2] Phase II Study of Imatinib in Advanced Chordoma
    Stacchiotti, Silvia
    Longhi, Alessandra
    Ferraresi, Virginia
    Grignani, Giovanni
    Comandone, Alessandro
    Stupp, Roger
    Bertuzzi, Alexia
    Tamborini, Elena
    Pilotti, Silvana
    Messina, Antonella
    Spreafico, Carlo
    Gronchi, Alessandro
    Amore, Paola
    Vinaccia, Vincenza
    Casali, Paolo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) : 914 - 920
  • [3] Imatinib mesylate in advanced chordoma: A multicenter phase II study
    Stacchiotti, S.
    Ferrari, S.
    Ferraresi, V.
    Grignani, G.
    Crippa, F.
    Messina, A.
    Spreafico, C.
    Tamborini, E.
    Gronchi, A.
    Casali, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
    Ramesh K. Ramanathan
    Chandra P. Belani
    Deepti A. Singh
    Michael Tanaka
    Heinz-Josef Lenz
    Yun Yen
    Hedy L. Kindler
    Syma Iqbal
    Jeff Longmate
    Philip C. Mack
    Georg Lurje
    Regina Gandour-Edwards
    Janet Dancey
    David R. Gandara
    Cancer Chemotherapy and Pharmacology, 2009, 64
  • [5] A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
    Ramanathan, Ramesh K.
    Belani, Chandra P.
    Singh, Deepti A.
    Tanaka, Michael
    Lenz, Heinz-Josef
    Yen, Yun
    Kindler, Hedy L.
    Iqbal, Syma
    Longmate, Jeff
    Mack, Philip C.
    Lurje, Georg
    Gandour-Edwards, Regina
    Dancey, Janet
    Gandara, David R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 777 - 783
  • [6] A Phase II study of the efficacy and tolerability of Lapatinib in patients with advanced hepatocellular carcinomas.
    Markowitz, Joseph
    Eng, Charis
    Sadee, Wolfgang
    Heerema, Nyla
    Li, Xiaobai
    Campbell, Angela
    Culler, Kristy
    O'Neil, Bert
    Lee, Ruey-min
    Zalupski, Mark
    Dancey, Janet
    Grever, Michael
    Villalona-Calero, Miguel
    Bekaii-Saab, Tanios
    CANCER RESEARCH, 2008, 68 (09)
  • [7] A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma: A Wisconsin Oncology Network study
    Frank, Daniel
    Jumonville, Alcee
    LoConte, Noelle K.
    Schelman, William R.
    Mulkerin, Daniel
    Lubner, Sam
    Richter, Katie
    Winterle, Natalie
    Wims, Mary Beth
    Dietrich, Leah
    Winkler, J. Mitchell
    Volk, Michael
    Kim, KyungMann
    Holen, Kyle D.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 3 (02) : 90 - 96
  • [8] Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin - A phase I study for advanced pancreaticobiliary cancer
    Safran, Howard
    Miner, Thomas
    Resnick, Murray
    Dipetrillo, Thomas
    McNulty, Brendan
    Evans, Devon
    Joseph, Plakyil
    Plette, Angela
    Millis, Robin
    Sears, Dina
    Gutman, Ned
    Kennedy, Teresa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 140 - 144
  • [9] A phase II trial of sorafenib (SO) in advanced chordoma patients (pt)
    Amela, Eric
    Bompas, Emmanuelle
    Le Cesne, Axel
    Tresch, Emmanuelle
    Italiano, Antoine
    Piperno-Neumann, Sophie
    Collard, Olivier
    Vansteene, Damien
    Domont, Julien
    Saada, Esma
    Isambert, Nicolas
    Salas, Sebastien
    Chevreau, Christine
    Bertucci, Francois
    Delaine, Stephanie Clisant
    Blay, Jean-Yves
    Penel, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
    Bekaii-Saab, Tanios
    Markowitz, Joseph
    Prescott, Nichole
    Sadee, Wolfgang
    Heerema, Nyla
    Wei, Lai
    Dai, Zunyan
    Papp, Audrey
    Campbell, Angela
    Culler, Kristy
    Balint, Catherine
    O'Neil, Bert
    Lee, Ruey-min
    Zalupski, Mark
    Dancey, Janet
    Chen, Helen
    Grever, Michael
    Eng, Charis
    Villalona-Calero, Miguel
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5895 - 5901